| 11/16/2026 3:30 PM | ABG Management Ltd. (1832106) Filed by Whitehawk Therapeutics (1422142) Subject | Form SCHEDULE 13G/A | |
| 11/16/2026 9:20 AM | Dellora Investments LP (1943462) Filed by Whitehawk Therapeutics (1422142) Subject | Form SCHEDULE 13G | |
| 11/13/2026 8:24 PM | Coastlands Capital LP (2068530) Filed by Whitehawk Therapeutics (1422142) Subject | Form SCHEDULE 13G/A | |
| 11/09/2026 3:07 PM | Whitehawk Therapeutics (1422142) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/09/2026 7:04 AM | Whitehawk Therapeutics (1422142) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/18/2026 3:40 PM | Dugan Margaret (1909734) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4/A | |
| 09/18/2026 3:41 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4/A | |
| 09/18/2026 3:43 PM | Dornan David (1821353) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4/A | |
| 09/18/2026 3:44 PM | BALL BRYAN (1766522) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4/A | |
| 09/18/2026 3:45 PM | Giacobello Scott M. (1754154) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4/A | |
| 09/15/2026 6:07 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for WHWK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Whitehawk Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/15/2026 6:05 PM | BALL BRYAN (1766522) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 6:05 PM | Dornan David (1821353) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 6:06 PM | Dugan Margaret (1909734) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 6:07 PM | Giacobello Scott M. (1754154) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2026 3:02 PM | Iyengar Vijay K (1670000) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 09/11/2026 3:04 PM | Iyengar Vijay K (1670000) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 4:02 PM | Whitehawk Therapeutics (1422142) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2026 4:57 PM | ORBIMED ADVISORS LLC (1055951) Filed by Whitehawk Therapeutics (1422142) Subject | Form SCHEDULE 13G/A | |
| 08/06/2026 3:03 PM | Whitehawk Therapeutics (1422142) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/06/2026 9:08 AM | Whitehawk Therapeutics (1422142) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/30/2026 3:04 PM | Dalal Anupam (1602474) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 4:23 PM | Hirmand Mohammad (1654482) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 4:24 PM | Maroun Richard E (1364590) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 4:26 PM | Reeve Emma (1680329) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 4:27 PM | Whitehawk Therapeutics (1422142) Issuer Zhao Baiteng (2049287) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 4:18 PM | Aghazadeh Behzad (1701815) Reporting Avoro Capital Advisors LLC (1633313) Reporting Avoro Ventures LLC (1879253) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 4:21 PM | Castelein Caley (1355758) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/15/2026 4:22 PM | Desai Neil (1878692) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2026 3:19 PM | Whitehawk Therapeutics (1422142) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2026 11:15 PM | Whitehawk Therapeutics (1422142) Filer | Form EFFECT | |
| 05/29/2026 3:17 PM | Whitehawk Therapeutics (1422142) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 05/21/2026 4:16 PM | Whitehawk Therapeutics (1422142) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 6:03 PM | ACUTA CAPITAL PARTNERS, LLC (1582844) Filed by Whitehawk Therapeutics (1422142) Subject | Form SCHEDULE 13D/A | |
| 05/18/2026 3:02 PM | Castelein Caley (1355758) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:03 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:04 PM | Giacobello Scott M. (1754154) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:05 PM | BALL BRYAN (1766522) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/18/2026 3:06 PM | Dugan Margaret (1909734) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 7:04 PM | Avoro Capital Advisors LLC (1633313) Filed by Whitehawk Therapeutics (1422142) Subject | Form SCHEDULE 13D/A | |
| 05/14/2026 6:40 PM | Aghazadeh Behzad (1701815) Reporting Avoro Capital Advisors LLC (1633313) Reporting Avoro Ventures LLC (1879253) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Federal Reserve Reveals Disturbing New Plan To Control Your Money (Ad) Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country.
Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this fall. Watch the video to learn how this plan could affect you |
| 05/13/2026 7:08 AM | Whitehawk Therapeutics (1422142) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/07/2026 8:12 AM | Whitehawk Therapeutics (1422142) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 3:19 PM | Whitehawk Therapeutics (1422142) Filer | Form DEF 14A | |
| 04/28/2026 3:20 PM | Whitehawk Therapeutics (1422142) Filer | Form ARS | |
| 04/17/2026 3:53 PM | Giacobello Scott M. (1754154) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 6:59 PM | BALL BRYAN (1766522) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 7:03 PM | Giacobello Scott M. (1754154) Reporting Whitehawk Therapeutics (1422142) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/13/2026 7:34 PM | BALL BRYAN (1766522) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/10/2026 5:46 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/09/2026 7:38 PM | BALL BRYAN (1766522) Reporting Whitehawk Therapeutics (1422142) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/09/2026 6:54 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/08/2026 7:32 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 5:22 PM | Dornan David (1821353) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 5:17 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 5:18 PM | Giacobello Scott M. (1754154) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 5:20 PM | BALL BRYAN (1766522) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 5:21 PM | Dugan Margaret (1909734) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 8:35 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/12/2026 3:49 PM | Whitehawk Therapeutics (1422142) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/12/2026 3:12 PM | Whitehawk Therapeutics (1422142) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/12/2026 7:02 AM | Whitehawk Therapeutics (1422142) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/10/2026 6:35 PM | BALL BRYAN (1766522) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/10/2026 6:36 PM | Giacobello Scott M. (1754154) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/10/2026 6:36 PM | Lennon David James (1995275) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/02/2025 3:46 PM | Dugan Margaret (1909734) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 12/02/2025 3:48 PM | Dugan Margaret (1909734) Reporting Whitehawk Therapeutics (1422142) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |